What is AmplifyBio?
AmplifyBio is a biotechnology firm headquartered in West Jefferson, Ohio. Operating within a dynamic and rapidly evolving industry, the company is positioned to leverage advancements in biological sciences for innovative solutions. The biotechnology sector is characterized by intensive research and development, high regulatory hurdles, and the potential for transformative market impact. AmplifyBio's focus within this broad field will dictate its specific market niche and competitive landscape.
How much funding has AmplifyBio raised?
AmplifyBio has raised a total of $50M across 1 funding round:
Debt
$50M
Debt (2023): $50M with participation from Hercules Capital
Key Investors in AmplifyBio
Hercules Capital
Hercules Capital is a South African investment company focused on the liquor and real estate sectors. It operates several liquor retail brands, including Prestons Liquor Stores and Big Daddys Liquor Stores, catering to both upmarket and bulk liquor customers. Additionally, Hercules Capital owns prime commercial properties through its real estate division, aiming to provide quality facilities for tenants. The company's mission is to create jobs and improve the socio-economic landscape of South Africa.
What's next for AmplifyBio?
The substantial enterprise-level funding indicates AmplifyBio is likely in a growth or scaling phase, aiming to expand its research capabilities, accelerate product development, or broaden its market reach. This strategic investment will be crucial for navigating the complexities of the biotechnology industry, which often requires significant capital for clinical trials, regulatory approvals, and commercialization. Future developments will likely focus on translating scientific breakthroughs into tangible products or services, solidifying its position and driving long-term value.
See full AmplifyBio company page
